GERN Gross Margin

The Gross Margin of Geron Corp (GERN) is 98.37%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

GERN Gross Margin - Historical Value

Date	Value
2024-12-31	98.37%

GERN Gross Margin - Peers Comparison

Ticker	Name	Value
APLT	Applied Therapeutics Inc	7775.20%
GMDA	Gamida Cell Ltd	18.50%
MIRM	Mirum Pharmaceuticals Inc	75.77%
SPRO	Spero Therapeutics Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
ISEE	IVERIC bio Inc	7775.20%
SMMT	Summit Therapeutics Inc	99.95%
ALDX	Aldeyra Therapeutics Inc	7775.20%
APS.TO	Aptose Biosciences Inc	100.00%
BCYC	Bicycle Therapeutics PLC	7775.20%
RAPT	Rapt Therapeutics Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
ABBV	Abbvie Inc	69.99%
BYSI	Beyondspring Inc	7775.20%
INZY	Inozyme Pharma Inc	7775.20%
MRNA	Moderna Inc	70.06%
OYST	Oyster Point Pharma Inc	93.79%
SPRB	Spruce Biosciences Inc	7775.20%
FHTX	Foghorn Therapeutics Inc.	7775.20%
GILD	Gilead Sciences Inc	78.26%
NLTX	Neoleukin Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
AMGN	Amgen Inc	61.53%
AUTL	Autolus Therapeutics PLC	-6.37%
AVRO	AVROBIO Inc	7775.20%
PSTX	Poseida Therapeutics Inc	7775.20%
SLDB	Solid Biosciences Inc	7775.20%
SYRS	Syros Pharmaceuticals Inc	7775.20%
950200.KQ	Psomagen Inc	23.13%
CRNX	Crinetics Pharmaceuticals Inc	7775.20%
ETNB	89Bio Inc	7775.20%
MREO	Mereo Biopharma Group PLC	74.26%
SNSE	Sensei Biotherapeutics Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
SELB	Selecta Biosciences Inc	7775.20%
VKTX	Viking Therapeutics Inc	7775.20%